BACKGROUND AND OBJECTIVES:Annualized mortality rates of chronic hemodialysis (CHD) patients in their first 90 d of treatment range from 24 to 50%. Limited studies also show high hospitalization rates. It was hypothesized that a structured quality improvement program (RightStart), focused on medical needs and patient education and support, would improve outcomes for incident CHD patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 918 CHD incident patients were prospectively enrolled in a multicenter RightStart Program, and compared with a time-concurrent group of 1020 control patients from non-RightStart clinics. RightStart patients received 3 mo of intervention in management of anemia, dosage of dialysis, nutrition, and dialysis access and a comprehensive educational program. Outcomes were tracked for up to 12 mo. RESULTS: At 3 mo, RightStart patients had higher albumin and hematocrit values. Dose of dialysis and permanent access placement were not statistically significantly different from control subjects. Compared with baseline, Mental Composite Score for RightStart patients improved significantly. Mean hospitalization days per patient year were reduced with RightStart versus control subjects. Mortality rates at 3, 6, and 12 mo were 20, 18, and 17 for RightStart patients versus 39, 33, and 30 deaths per 100 patient-years for control subjects, respectively. CONCLUSIONS: A structured program of prompt medical and educational strategies in incident CHD patients results in improved morbidity and mortality that last up to 1 yr.
RCT Entities:
BACKGROUND AND OBJECTIVES: Annualized mortality rates of chronic hemodialysis (CHD) patients in their first 90 d of treatment range from 24 to 50%. Limited studies also show high hospitalization rates. It was hypothesized that a structured quality improvement program (RightStart), focused on medical needs and patient education and support, would improve outcomes for incident CHD patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 918 CHD incident patients were prospectively enrolled in a multicenter RightStart Program, and compared with a time-concurrent group of 1020 control patients from non-RightStart clinics. RightStart patients received 3 mo of intervention in management of anemia, dosage of dialysis, nutrition, and dialysis access and a comprehensive educational program. Outcomes were tracked for up to 12 mo. RESULTS: At 3 mo, RightStart patients had higher albumin and hematocrit values. Dose of dialysis and permanent access placement were not statistically significantly different from control subjects. Compared with baseline, Mental Composite Score for RightStart patients improved significantly. Mean hospitalization days per patient year were reduced with RightStart versus control subjects. Mortality rates at 3, 6, and 12 mo were 20, 18, and 17 for RightStart patients versus 39, 33, and 30 deaths per 100 patient-years for control subjects, respectively. CONCLUSIONS: A structured program of prompt medical and educational strategies in incident CHD patients results in improved morbidity and mortality that last up to 1 yr.
Authors: Kerri L Cavanaugh; Rebecca L Wingard; Raymond M Hakim; Svetlana Eden; Ayumi Shintani; Kenneth A Wallston; Mary Margaret Huizinga; Tom A Elasy; Russell L Rothman; T Alp Ikizler Journal: J Am Soc Nephrol Date: 2010-07-29 Impact factor: 10.121
Authors: Kevin E Chan; Frank W Maddux; Nina Tolkoff-Rubin; S Ananth Karumanchi; Ravi Thadhani; Raymond M Hakim Journal: Clin J Am Soc Nephrol Date: 2011-09-29 Impact factor: 8.237
Authors: Denise M Hynes; Michael Fischer; Marian Fitzgibbon; Anna C Porter; Michael Berbaum; Linda Schiffer; Ifeanyi B Chukwudozie; Hai Nguyen; Jose Arruda Journal: J Gen Intern Med Date: 2019-07-24 Impact factor: 5.128
Authors: Anna C Porter; Marian L Fitzgibbon; Michael J Fischer; Rani Gallardo; Michael L Berbaum; James P Lash; Sheila Castillo; Linda Schiffer; Lisa K Sharp; John Tulley; Jose A Arruda; Denise M Hynes Journal: Contemp Clin Trials Date: 2015-02-28 Impact factor: 2.226
Authors: Kerri L Cavanaugh; Rebecca L Wingard; Raymond M Hakim; Tom A Elasy; T Alp Ikizler Journal: Clin J Am Soc Nephrol Date: 2009-04-23 Impact factor: 8.237